Yanan Yu

机构：Qingdao University, Beijing Institute of Technology, Affiliated Hospital of Qingdao University, The University of Texas Health Science Center at Houston · ORCID：0000-0002-7530-1647

发表论文 56 篇 · 总被引 3817 次 · h-index 19

代表论文

• Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice (2020 · European Journal of Nutrition · 被引 207)
• The Impact of Preoperative Sarcopenia on Survival Prognosis in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer: A Systematic Review and Meta-Analysis (2021 · Frontiers in Oncology · 被引 39)
• Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery (2022 · Gland Surgery · 被引 32)
• Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection ( SHARE2301 ): A Multicenter, Noninferiority, Randomized Clinical Trial (2024 · Helicobacter · 被引 31)
• Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer (2022 · Frontiers in Surgery · 被引 20)
• LINC00511-dependent inhibition of IL-24 contributes to the oncogenic role of HNF4α in colorectal cancer (2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 13)